–Jin Yang-gon, CEO of HLB. Source = Newsis
–
[이코노믹리뷰=황진중 기자] HLB (028300) is scheduled to disclose its position on the 16th in relation to the report on the suspicion of false disclosure of FDA clinical results.
On the website, HLB said, “After receiving a request from the financial authorities, we express our deep regret that the fact that has not been confirmed as a situation that has not been confirmed is prematurely reported, causing confusion between the market and investors. I will hold you accountable.”
HLB added, “We will convey our position on this issue in detail through our YouTube channel at 2 pm today.” He added, “I am very sorry for causing concern to shareholders.”
– .
Related posts:
Proof that you have not taken out a loan in the last 20 years, have not requested any Corona aid, ha...
OPEC+ unexpectedly announced that the meeting would be postponed for 4 days. Oil prices plunged more...
Plérin: Tuesday, a debate on education without violence, with the social center - Plérin
Send out! 'Dtac' heals the rat customer, 'half per person' gives away free calls - internet - disco...
